ME Therapeutics

ME Therapeutics is an early-stage biotechnology company based in Vancouver, dedicated to the discovery and development of novel cancer immunotherapies targeting immune suppression in cancer. Our primary focus is on overcoming the suppressive effects of a key class of immune cells—myeloid cells—to enhance anti-tumor immunity.